MicroRNA-126 is a prospective target for vascular disease

  • Qu M
  • Pan J
  • Shi X
  • et al.
N/ACitations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

MicroRNA-126 was involved in angiogenesis during physiological and pathological process. It was mainly expressed in endothelial cells, and defined as a pivotal biological molecule associated with vascular disease. Increased microRNA-126 in endothelial cells promotes angiogenesis in ischemic stroke, repairs impaired endothelial cells in atherosclerosis, and attenuates vascular dysfunction in diabetics. By contrast, microRNA-126 transferred from endothelial cell to smooth muscle cells could lead to proliferation that induced intimal hyperplasia. Additionally, microRNA-126 could be a tumor suppressor or an oncogene, which was depended on the cancer type. In this review, we summarized the function of microRNA-126 in ischemic stroke, atherosclerosis, diabetics, tumor, and discussed the underlying mechanisms.Copyright © The Author(s) 2018.

Cite

CITATION STYLE

APA

Qu, M.-J., Pan, J.-J., Shi, X.-J., Zhang, Z.-J., Tang, Y.-H., & Yang, G.-Y. (2018). MicroRNA-126 is a prospective target for vascular disease. Neuroimmunology and Neuroinflammation, 5(4), 10. https://doi.org/10.20517/2347-8659.2018.01

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free